CDK2-IN-14

• Description:

  CDK2-IN-14 (compound 4f) is a highly selective CDK2 inhibitor. CDK2-IN-14 can be used in research of cancer[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk2-in-14.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=S(C1=CC=C(NC2=NC=C(C34CC3)C(N([C@H]5[C@](C)(O)CCC5)C4=O)=N2)C=C1)(NC)=O

• Molecular Formula:

  C21H25N5O4S

• Molecular Weight:

  443.52

• References & Citations:

  [1]Sokolsky A, et al. Discovery of 5, 7-Dihydro-6 H-pyrrolo [2, 3-d] pyrimidin-6-ones as Highly Selective CDK2 Inhibitors. ACS Medicinal Chemistry Letters, 2022.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2862836-22-2]